CEO, Medicare Advantage
Avg Cost/Share
$2.53
Shares
2,102
Total Value
$5,318.06
Owned After
2,757,029
SEC Form 4
CEO, Medicare Advantage
Avg Cost/Share
$2.61
Shares
4,913
Total Value
$12,822.93
Owned After
2,757,029
SEC Form 4
CEO, Medicare Advantage
Avg Cost/Share
$3.58
Shares
30,385
Total Value
$108,778.30
Owned After
2,757,029
SEC Form 4
CEO, Medicare Advantage
Avg Cost/Share
$2.69
Shares
16,514
Total Value
$44,422.66
Owned After
2,757,029
SEC Form 4
CEO, Medicare Advantage
Avg Cost/Share
$2.65
Shares
2,012
Total Value
$5,331.80
Owned After
2,757,029
SEC Form 4
CEO, Medicare Advantage
Avg Cost/Share
$3.09
Shares
4,914
Total Value
$15,184.26
Owned After
2,757,029
SEC Form 4
CEO, Medicare Advantage
Avg Cost/Share
$2.86
Shares
20,450
Total Value
$58,487.00
Owned After
2,757,029
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Jan 7, 2026 | Sell | $2.53 | 2,102 | $5,318.06 | 2,757,029 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Dec 18, 2025 | Sell | $2.61 | 4,913 | $12,822.93 | 2,757,029 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Nov 4, 2025 | Sell | $3.58 | 30,385 | $108,778.30 | 2,757,029 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Oct 17, 2025 | Sell | $2.69 | 16,514 | $44,422.66 | 2,757,029 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Oct 7, 2025 | Sell | $2.65 | 2,012 | $5,331.80 | 2,757,029 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Sep 17, 2025 | Sell | $3.09 | 4,914 | $15,184.26 | 2,757,029 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Jun 17, 2025 | Sell | $2.86 | 20,450 | $58,487.00 | 2,757,029 |